Shares of Doximity (NYSE: DOCS) plunged about 22% in pre-market trading on Friday after the company issued weaker-than-expected revenue guidance
8 months ago
UnitedHealth Group (NYSE: UNH) saw its shares tumble over 17% on Tuesday after the company withdrew its full-year 2025 guidance
Exelixis (NASDAQ: EXEL) shares jumped over 6% in pre-market trading on Wednesday after the company reported better-than-expected first-quarter results and
DaVita (NYSE: DVA) reported first-quarter 2025 results that came in slightly ahead of Wall Street estimates, supported by steady treatment
Shares of Novo Nordisk (NYSE: NVO) fell more than 3% in pre-market trading Monday after Eli Lilly’s Zepbound outperformed Wegovy
Hims & Hers Health (NYSE: HIMS) stock surged more than 18% in regular trading on Tuesday after several analysts raised
Shares of Organon (NYSE: OGN) plunged by 27% during regular trading on Thursday, reaching a new 52-week low of $9.25.
Shares of Eli Lilly (NYSE: LLY) fell sharply on Thursday, dropping more than 11% in regular trading after the company
Shares of Hims & Hers Health (NYSE: HIMS) surged over 23% in intraday trading on Tuesday, following the announcement of
UnitedHealth Group (NYSE: UNH) shares fell 22% during regular trading on Thursday after the healthcare giant reported disappointing first-quarter results
9 months ago
Shares of Hims & Hers Health (NYSE: HIMS) fell 9% on Thursday after Chief Operating Officer Melissa Baird sold $910,687
Walgreens Boots Alliance (NASDAQ: WBA) reported fiscal second-quarter results that topped Wall Street expectations on both the top and bottom
